Status:
UNKNOWN
Posterior Segment Evaluation of Patients With SLE Using OCT and OCTA
Lead Sponsor:
Minia University
Conditions:
SLE (Systemic Lupus)
Eligibility:
All Genders
18-60 years
Brief Summary
Aim of The Study To evaluate different structural retinal changes using OCT and OCT-A in patients with SLE ; newly diagnosed patients and patients on treatment and compare parameters with normal subje...
Detailed Description
Systemic lupus erythematosus (SLE) is a chronic autoimmune inflammatory disease that involves different organs and systems. The heterogeneous nature of the disease represents a great challenge in it...
Eligibility Criteria
Inclusion
- Age ≥18 years old.
- Patients with SLE diagnosed by a Rheumatologist with no ocular involvement upon clinical examination
Exclusion
- Patients with history of intraocular surgery as cataract surgery retinal detachment surgery and anti-glaucoma surgery.
- Patients with significant media opacity as corneal opacity, cataract.
- Patients with ocular diseases as glaucoma, uveitis.
- Patients with any retinal affection as pathological myopia, macular hole, age related macular degeneration and retinal vascular occlusion.
- Patients with systemic diseases as diabetes mellitus (DM), hypertension, abnormal kidney functions
Key Trial Info
Start Date :
June 4 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2021
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04866615
Start Date
June 4 2021
End Date
November 1 2021
Last Update
July 7 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Minia university hospital
Minya, Egypt